Impact of COVID-19 on Business Activities and Performance
First written in FY2021-Q1. 7 of 16 entries say "Mitigated", first in FY2022-Q1. Latest entry: FY2026.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2026DroppedAnnual report
「Spread of infectious diseases」
COVID-19 is no longer presented as an independent risk and earnings factor and has instead been classified under natural disaster risk as a general pandemic risk. - FY2024RestatedAnnual report
「In the nail-related business, the overall market and trade show participation, among other factors, have not yet reached pre-pandemic levels.」
While the impact of the infection eased in the dental-related business, the company continues to indicate that the market and trade shows in the nail-related business have not reached pre-pandemic levels. - FY2024-Q2MitigatedAnnual report
「In Japan, the domestic professional market, centered on trade shows, was returning to pre-pandemic conditions, and sales of the core gel nail products increased, resulting in higher sales year on year.」
The disclosure states that the professional market in the domestic nail-related business was returning to pre-pandemic conditions, indicating that the impact of the infection had eased. - FY2024-Q1MitigatedAnnual report
「In Japan, the domestic professional market, centered on trade shows, was returning to pre-pandemic conditions, and sales of the core gel nail products increased, resulting in higher sales year on year.」
The disclosure states that the domestic professional market in the nail-related business was returning to pre-pandemic conditions, indicating that the impact of the infection had eased. - FY2023MitigatedAnnual report
「In the dental industry, the impact of COVID-19 has gradually begun to subside」
The disclosure states that the impact of the infection has gradually begun to subside across the dental industry as a whole. Meanwhile, the impact remains in some businesses, including the nail business. - FY2023-Q3MitigatedAnnual report
「In Taiwan, the business moved beyond the impact of the rapid spread of infections and demand recovered, resulting in higher sales year on year.」
The disclosure states that the Taiwan nail-related business moved beyond the impact of the rapid spread of infections and that demand recovered. - FY2023-Q2MitigatedAnnual report
「In Taiwan, the business moved beyond the impact of the rapid spread of infections and demand recovered, resulting in higher sales year on year.」
The disclosure states that the Taiwan nail-related business moved beyond the impact of the rapid spread of infections and that demand recovered. - FY2023-Q1MitigatedAnnual report
「In Taiwan, the business was also moving beyond the impact of the rapid spread of infections, resulting in higher sales year on year.」
The disclosure states that the Taiwan nail-related business was recovering from the impact of the rapid spread of infections and recorded higher sales year on year. - FY2022Updated the full-year impact statusAnnual report
「In Japan, sales of the company's core gel nail products remained sluggish due to activity restrictions resulting from the resurgence of infections and the impact of the end of stay-at-home demand, resulting in lower sales year on year.」
While demand recovery was seen in the dental-related business, the impact of activity restrictions and the end of stay-at-home demand remained through the full year as factors behind lower sales in the nail-related business. - FY2022-Q3MaterialisedAnnual report
「In Japan, sales of the company's core gel nail-related products declined due to the impact of activity restrictions associated with the resurgence of infections and the easing of stay-at-home demand, resulting in lower sales year on year. Overseas, web sales in the United States remained strong due to proactive promotional activities on social media, but sales in Taiwan declined due to the impact of a rapid spread of infections, resulting in lower sales year on year.」
The impact of the infection eased in the overseas dental-related business, while lower sales continued to be recorded in the domestic nail business due to activity restrictions and in Taiwan due to the rapid spread of infections. - FY2022-Q2MaterialisedAnnual report
「In Japan, sales of the company's core gel nail-related products declined due to the impact of activity restrictions associated with the resurgence of infections and the easing of stay-at-home demand, resulting in lower sales year on year. Overseas, web sales in the United States remained strong due to proactive promotional activities on social media, but sales in Taiwan declined due to the impact of a rapid spread of infections, resulting in lower sales year on year.」
The impact of the infection eased in the overseas dental-related business, while lower sales were recorded in the domestic nail business due to activity restrictions and in Taiwan due to the rapid spread of infections. - FY2022-Q1MitigatedAnnual report
「Overseas, the impact of the novel coronavirus disease eased, and conditions remained strong in each region, including efforts to expand sales of existing products mainly in North America, Europe and China. In addition, foreign exchange fluctuations contributed to a year-on-year increase in revenue.」
The disclosure states that the impact of the infection eased in the overseas dental-related business, resulting in higher sales in each region. Meanwhile, it also states that the domestic nail business is still recovering and does not consider the impact to have been eliminated. - FY2021MaterialisedAnnual report
「The Group's revenue for the consolidated fiscal year was ¥24,680 million, down ¥1,428 million, or 5.5%, year on year.」
Amid the impact of COVID-19, full-year consolidated net sales were ¥24,680 million, down 5.5% year on year. - FY2021-Q3MaterialisedAnnual report
「The group's revenue for the nine months ended the third quarter was ¥17,748 million, a decrease of ¥1,853 million, or 9.5%, from the same period of the previous year due to the impact of COVID-19.」
The impact of COVID-19 continued, and consolidated revenue declined 9.5% year on year. - FY2021-Q2MaterialisedAnnual report
「The group's revenue for the six months ended the second quarter was ¥11,217 million, a decrease of ¥2,203 million, or 16.4%, from the same period of the previous year due to the impact of COVID-19.」
The impact of COVID-19 continued, and consolidated revenue declined 16.4% year on year. The Business and Other Risks section states that there were no new risks, while the impact on operating performance is reported as having materialized. - FY2021-Q1MaterialisedAnnual report
「The group's revenue for the first quarter of the fiscal year was ¥4,877 million, a decrease of ¥1,583 million, or 24.5%, from the same period of the previous year due to the impact of COVID-19. In Japan, products including the digital intraoral camera system "アイスペシャル C-Ⅳ," launched in the previous fiscal year, and the dental milling resin material "松風ブロックHC スーパーハード" contributed to revenue. However, revenue declined year on year because the pandemic reduced opportunities for patients to receive dental care and restricted sales activities.」
The Business and Other Risks section states that no new risks had arisen, while the discussion of operating results states that the effects had materialized, including fewer opportunities to receive dental care, restrictions on sales activities and a 24.5% year-on-year decline in consolidated revenue due to the pandemic.